Analysis of ER-Phagy in cancer drug resistance
Date
2022
Authors
Chipurupalli, S.
Desiderio, V.
Robinson, N.
Editors
Baiocchi, B.
M, M.
M, M.
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Book chapter
Citation
Source details - Title: Cancer Drug Resistance, 2022 / Baiocchi, B., M, M. (ed./s), vol.2535, Ch.16, pp.211-220
Statement of Responsibility
Conference Name
Abstract
The ability of the cancer cells to survive hostile environment depends on their cellular stress response mechanisms. These mechanisms also help them to develop resistance to chemotherapies. Autophagy and more specifically organelle specific autophagy is one such adaptive mechanism that promotes drug resistance in cancer cells. Endoplasmic reticulum–specific autophagy or ER-phagy has been more recently described to overcome ER-stress through the degradation of damaged ER. ER-resident proteins such as FAM134B act as ER-phagy receptors to specifically target damaged ER for degradation through autophagy. Moreover, we had recently deciphered that ER-phagy facilitates cancer cell survival during hypoxic stress and we predict that this process could play a critical role in the development of drug resistance in cancer cells. Therefore, here, we provide a lay description of how ER-phagy could be investigated biochemically by Western blot analysis and silencing ER-phagy receptor genes using small interfering RNAs (siRNA).
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.